Figure S1. Size distribution (predominantly around 20Â kb) was estimated by electrophoresis. (DOCX 62Â kb
Figure S1. Ferric Reducing Antioxidant Power (FRAP) in plasma. Data are mean ± SEM for n = 12 per gr...
Increasing evidence has demonstrated the benefits of α-linolenic acid-rich flaxseed oil (ALA-FO) aga...
The development and progression of alcoholic fatty liver disease (AFLD) is influenced by the intesti...
Table S2. Fatty acid composition (%) of dietary fats contained in liquid diets. (DOCX 12Â kb
Figure S3. NMDS analysis showed the difference in terms of species in fecal samples. Beta diversity ...
Dietary flaxseed (FS) and its components including FS oil (FSO), secoisolariciresinol diglucoside (S...
Non-alcoholic steatohepatitis (NASH) is gradually becoming one of the most common and health-endange...
IntroductionNon-alcoholic fatty liver diseases (NAFLD), along with the complications of obesity and ...
Essential polyunsaturated fatty acids (PUFAs) in the feed may affect the gastrointestinal microbiota...
Flaxseed (FS) is an oilseed rich in α-linolenic acid, lignans, and dietary fiber. Due to this unique...
BACKGROUND & AIMS: Alcoholic liver disease is a leading cause of mortality. Chronic alcohol consumpt...
Additional file 1: Fig. S1. Brain cysts of ICR mice infected with the corresponding cysts. **P < 0.0...
Background: Flaxseed (FS), a nutritional supplement consisting mainly of omega-3 fatty acids and lig...
Table S1. The content of major components in SCLE. Figure S1 Chromatograms of standard mixture (A) a...
Inflammatory and metabolic profiling in control and STAT mice. Serum was collected at 32 weeks for a...
Figure S1. Ferric Reducing Antioxidant Power (FRAP) in plasma. Data are mean ± SEM for n = 12 per gr...
Increasing evidence has demonstrated the benefits of α-linolenic acid-rich flaxseed oil (ALA-FO) aga...
The development and progression of alcoholic fatty liver disease (AFLD) is influenced by the intesti...
Table S2. Fatty acid composition (%) of dietary fats contained in liquid diets. (DOCX 12Â kb
Figure S3. NMDS analysis showed the difference in terms of species in fecal samples. Beta diversity ...
Dietary flaxseed (FS) and its components including FS oil (FSO), secoisolariciresinol diglucoside (S...
Non-alcoholic steatohepatitis (NASH) is gradually becoming one of the most common and health-endange...
IntroductionNon-alcoholic fatty liver diseases (NAFLD), along with the complications of obesity and ...
Essential polyunsaturated fatty acids (PUFAs) in the feed may affect the gastrointestinal microbiota...
Flaxseed (FS) is an oilseed rich in α-linolenic acid, lignans, and dietary fiber. Due to this unique...
BACKGROUND & AIMS: Alcoholic liver disease is a leading cause of mortality. Chronic alcohol consumpt...
Additional file 1: Fig. S1. Brain cysts of ICR mice infected with the corresponding cysts. **P < 0.0...
Background: Flaxseed (FS), a nutritional supplement consisting mainly of omega-3 fatty acids and lig...
Table S1. The content of major components in SCLE. Figure S1 Chromatograms of standard mixture (A) a...
Inflammatory and metabolic profiling in control and STAT mice. Serum was collected at 32 weeks for a...
Figure S1. Ferric Reducing Antioxidant Power (FRAP) in plasma. Data are mean ± SEM for n = 12 per gr...
Increasing evidence has demonstrated the benefits of α-linolenic acid-rich flaxseed oil (ALA-FO) aga...
The development and progression of alcoholic fatty liver disease (AFLD) is influenced by the intesti...
DOI
Add to ORKG